This article is authored by Ranjit Barshikar, CEO, QbD International, CGMP Consulting, United Nations Adviser.

Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent ...

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.

CDMOs also employ highly experienced professionals, many of whom can offer their expertise in navigating the highly complex aspects of the pharmaceutical manufacturing process. Over the past ...

The consortium will look to create systems equipped with automated visual inspection and in-line process and product quality monitoring, all of which will require a new generation of skilled ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

This study reveals efficient synthesis of ibuprofen:nicotinamide co-crystals via mechanochemistry, highlighting ...

Asia Pacific pharmaceutical manufacturing industry market will grow by 11.3% annually with a total addressable market cap of $57.26 billion over 2023-2032. The growth is driven by the increased drug ...

Securing FDA clearance or approval is a major accomplishment for medical device and pharmaceutical companies, but it’s not ...

groninger, a German manufacturer of filling and closing machines for the pharmaceutical, consumer healthcare and cosmetics industries, is expanding its U.S. headquarters in Charlotte. groninger USA ...

manufacturing process for its PL-14 allergy blocker in preparation for its planned 2025 clinical trial. The company works closely with Eurofins CDMO, having recently entered into a manufacturing ...